Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
1.580
-0.070 (-4.24%)
At close: Jul 18, 2025, 4:00 PM
1.630
+0.050 (3.16%)
After-hours: Jul 18, 2025, 7:33 PM EDT
Company Description
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.
Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Autonomix Medical, Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Bradley Hauser |
Contact Details
Address: 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 United States | |
| Phone | 713 588 6150 |
| Website | autonomix.com |
Stock Details
| Ticker Symbol | AMIX |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001617867 |
| CUSIP Number | 05330T106 |
| ISIN Number | US05330T2050 |
| Employer ID | 47-1607810 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Bradley Hauser | President, Chief Executive Officer and Director |
| Walter V. Klemp | Executive Chairman |
| Lori H. Bisson | Executive Vice Chairman |
| Dr. Robert Schwartz M.D. | Co-Founder and Chief Medical Officer |
| Landy Toth | Co-Founder and Chief Technology Officer |
| Trent N. Smith CPA | Executive Vice President and Chief Financial Officer |
| Jennifer Cook | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 11, 2025 | EFFECT | Notice of Effectiveness |
| Jul 3, 2025 | POS AM | Post-Effective amendments for registration statement |
| May 29, 2025 | 10-K | Annual Report |
| Apr 30, 2025 | 8-K | Current Report |
| Mar 11, 2025 | EFFECT | Notice of Effectiveness |
| Mar 7, 2025 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Mar 7, 2025 | UPLOAD | Filing |
| Feb 28, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Feb 28, 2025 | 8-K | Current Report |
| Feb 13, 2025 | 8-K | Current Report |